Table 5.

Adjusted Cox Proportional Hazards Model for Testosterone Recovery after ADT Cessation

5A - Normalization of Testosterone (T>300ng/dl)
Parameter	HR	95% CI	P value
ADT Duration <6m	1.47	1.06–2.04	0.02
Patient Age <65y	1.72	1.20–2.47	<0.01
Baseline TT >400 ng/dl	1.28	0.93–1.77	0.13
Diabetes	0.60	0.33–1.07	0.08
Sleep Apnea	1.53	0.84–2.79	0.16
5B - Recovery above Castrate Level (T>50ng/dl)
Parameter	HR	95% CI	P value
ADT duration <6m	1.28	1.00 – 1.64	0.05
Patient Age <65y	1.46	1.12 – 1.92	0.006
Baseline TT >400 ng/dl	1.11	0.87 – 1.42	0.41
Diabetes	0.83	0.57–1.20	0.32
Sleep Apnea	1.33	0.84–2.11	0.22
5C - Testosterone Recovery to Baseline Levels
Parameter	HR	95% CI	P value
ADT duration < 6m	1.35	0.98 – 1.85	0.07
Patient Age < 65y	2.08	1.45 – 2.98	<0.001
Baseline T > 400 ng/dl	0.51	0.36 – 0.72	<0.001
Diabetes	0.42	0.24–0.73	0.002
Sleep Apnea	1.11	0.60–2.03	0.75